ARROWHEAD PHARMACEUTICALS, INC.
Industry: Life Sciences ・ $ARWR on Nasdaq
Insider Sale
+$1,407,600
-9.08%
Shares
Shares Volume: 40,000 Shares
Average Share Price: $35.19
INSIDER
Myszkowski Kenneth Allen
Chief Financial Officer (Officer)
reported on Mar 8 2024
traded on Mar 6 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 400,600 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $837,489.52 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 22 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $711,100.95 |
| COMPANY PREVIOUS TRADES |